US Stock MarketDetailed Quotes

NVO Novo-Nordisk A/S

Watchlist
  • 106.800
  • +0.670+0.63%
Close Nov 29 13:00 ET
  • 109.580
  • +2.780+2.60%
Pre 06:11 ET
475.91BMarket Cap35.52P/E (TTM)

Novo-Nordisk A/S Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
21.42%71.31B
25.34%68.06B
22.45%65.35B
31.26%232.26B
36.95%65.86B
28.89%58.73B
31.59%54.3B
26.97%53.37B
25.68%176.95B
25.46%48.09B
Operating revenue
21.42%71.31B
25.34%68.06B
22.45%65.35B
33.56%608.65B
35.31%442.25B
28.89%58.73B
31.59%54.3B
26.97%53.37B
33.96%455.69B
37.49%326.83B
Cost of revenue
16.42%11.31B
30.78%10.27B
21.19%9.92B
25.72%35.77B
21.21%10.01B
34.90%9.71B
29.44%7.86B
18.29%8.18B
20.25%28.45B
32.38%8.26B
Gross profit
22.41%60B
24.42%57.79B
22.68%55.43B
32.32%196.5B
40.22%55.85B
27.76%49.02B
31.96%46.44B
28.68%45.19B
26.77%148.51B
24.11%39.83B
Operating expense
18.44%26.18B
41.21%31.85B
16.89%23.59B
27.44%93.92B
27.88%29.08B
21.58%22.11B
34.22%22.56B
26.37%20.18B
25.98%73.7B
23.21%22.74B
Selling and administrative expenses
17.88%16.59B
4.39%16.09B
6.90%14.41B
21.53%61.6B
23.42%18.63B
11.63%14.08B
30.28%15.41B
20.89%13.48B
23.44%50.68B
17.70%15.09B
-Selling and marketing expense
18.65%15.21B
4.13%14.93B
6.80%13.26B
22.78%56.74B
24.94%17.17B
11.95%12.82B
32.31%14.34B
21.89%12.41B
24.88%46.22B
18.15%13.74B
-General and administrative expense
10.03%1.38B
7.93%1.16B
8.03%1.16B
8.69%4.86B
8.01%1.46B
8.46%1.26B
8.17%1.07B
10.41%1.07B
10.30%4.47B
13.28%1.35B
Research and development costs
16.73%9.49B
126.83%16.17B
27.91%8.61B
34.91%32.44B
29.38%10.46B
44.29%8.13B
39.12%7.13B
29.24%6.73B
35.31%24.05B
43.55%8.09B
Other operating expenses
203.06%101M
-2,800.00%-405M
1,821.21%568M
88.49%-119M
99.31%-3M
-63.33%-98M
110.07%15M
91.58%-33M
-211.45%-1.03B
-10,925.00%-433M
Operating profit
25.67%33.82B
8.56%25.93B
27.35%31.85B
37.11%102.57B
56.65%26.77B
33.34%26.91B
29.89%23.89B
30.61%25.01B
27.56%74.81B
25.33%17.09B
Net non-operating interest income expense
-51.13%562M
-264.48%-602M
126.67%72M
203.13%330M
-119.67%-916M
153.44%1.15B
122.93%366M
78.01%-270M
-77.78%-320M
509.50%4.66B
Non-operating interest income
-58.32%1.38B
48.38%960M
151.88%2.15B
347.28%1.07B
11.88%-2.82B
110.93%3.32B
-60.93%647M
305.71%852M
3.46%239M
-33.22%-3.2B
Non-operating interest expense
-62.13%821M
455.87%1.56B
84.85%2.07B
43.39%542M
73.86%-2.1B
-41.80%2.17B
-91.36%281M
-21.97%1.12B
30.80%378M
-479.45%-8.04B
Total other finance cost
----
----
----
8.84%197M
----
----
----
----
48.36%181M
----
Other net income (expense)
132.61%1.77B
-981.01%-5.43B
Gain on sale of security
----
----
----
132.25%1.69B
----
----
----
----
-918.44%-5.24B
----
Earnings from equity interest
----
----
----
142.86%81M
----
----
----
----
-687.50%-189M
----
Income before tax
22.52%34.38B
4.44%25.33B
29.03%31.92B
51.57%104.67B
69.28%27.62B
55.63%28.06B
44.41%24.25B
38.05%24.74B
16.90%69.06B
24.43%16.32B
Income tax
26.82%7.08B
9.45%5.28B
32.26%6.51B
55.06%20.99B
107.67%5.66B
53.98%5.59B
38.80%4.83B
32.73%4.92B
19.55%13.54B
22.65%2.72B
Net income
21.46%27.3B
3.20%20.05B
28.23%25.41B
50.71%83.68B
61.59%21.96B
56.04%22.48B
45.88%19.43B
39.44%19.81B
16.27%55.53B
24.79%13.59B
Net income continuous Operations
21.46%27.3B
3.20%20.05B
28.23%25.41B
50.71%83.68B
61.59%21.96B
56.04%22.48B
45.88%19.43B
39.44%19.81B
16.27%55.53B
24.79%13.59B
Minority interest income
Net income attributable to the parent company
21.46%27.3B
3.20%20.05B
28.23%25.41B
50.71%83.68B
61.59%21.96B
56.04%22.48B
45.88%19.43B
39.44%19.81B
16.27%55.53B
24.79%13.59B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
21.46%27.3B
3.20%20.05B
28.23%25.41B
50.71%83.68B
61.59%21.96B
56.04%22.48B
45.88%19.43B
39.44%19.81B
16.27%55.53B
24.79%13.59B
Basic earnings per share
22.11%6.13
3.93%4.5
29.55%5.7
52.28%18.67
62.91%4.92
57.37%5.02
47.53%4.33
41.03%4.4
17.88%12.26
26.36%3.02
Diluted earnings per share
22.40%6.12
3.94%4.49
29.38%5.68
52.37%18.62
63.12%4.91
57.73%5
47.44%4.32
41.16%4.39
17.84%12.22
26.47%3.01
Dividend per share
15.51%3.4797
0
59.41%6.4281
26.94%7.0451
0
40.55%3.0126
0
18.37%4.0325
19.10%5.55
0
Currency Unit
DKK
DKK
DKK
DKK
DKK
DKK
DKK
DKK
DKK
DKK
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 21.42%71.31B25.34%68.06B22.45%65.35B31.26%232.26B36.95%65.86B28.89%58.73B31.59%54.3B26.97%53.37B25.68%176.95B25.46%48.09B
Operating revenue 21.42%71.31B25.34%68.06B22.45%65.35B33.56%608.65B35.31%442.25B28.89%58.73B31.59%54.3B26.97%53.37B33.96%455.69B37.49%326.83B
Cost of revenue 16.42%11.31B30.78%10.27B21.19%9.92B25.72%35.77B21.21%10.01B34.90%9.71B29.44%7.86B18.29%8.18B20.25%28.45B32.38%8.26B
Gross profit 22.41%60B24.42%57.79B22.68%55.43B32.32%196.5B40.22%55.85B27.76%49.02B31.96%46.44B28.68%45.19B26.77%148.51B24.11%39.83B
Operating expense 18.44%26.18B41.21%31.85B16.89%23.59B27.44%93.92B27.88%29.08B21.58%22.11B34.22%22.56B26.37%20.18B25.98%73.7B23.21%22.74B
Selling and administrative expenses 17.88%16.59B4.39%16.09B6.90%14.41B21.53%61.6B23.42%18.63B11.63%14.08B30.28%15.41B20.89%13.48B23.44%50.68B17.70%15.09B
-Selling and marketing expense 18.65%15.21B4.13%14.93B6.80%13.26B22.78%56.74B24.94%17.17B11.95%12.82B32.31%14.34B21.89%12.41B24.88%46.22B18.15%13.74B
-General and administrative expense 10.03%1.38B7.93%1.16B8.03%1.16B8.69%4.86B8.01%1.46B8.46%1.26B8.17%1.07B10.41%1.07B10.30%4.47B13.28%1.35B
Research and development costs 16.73%9.49B126.83%16.17B27.91%8.61B34.91%32.44B29.38%10.46B44.29%8.13B39.12%7.13B29.24%6.73B35.31%24.05B43.55%8.09B
Other operating expenses 203.06%101M-2,800.00%-405M1,821.21%568M88.49%-119M99.31%-3M-63.33%-98M110.07%15M91.58%-33M-211.45%-1.03B-10,925.00%-433M
Operating profit 25.67%33.82B8.56%25.93B27.35%31.85B37.11%102.57B56.65%26.77B33.34%26.91B29.89%23.89B30.61%25.01B27.56%74.81B25.33%17.09B
Net non-operating interest income expense -51.13%562M-264.48%-602M126.67%72M203.13%330M-119.67%-916M153.44%1.15B122.93%366M78.01%-270M-77.78%-320M509.50%4.66B
Non-operating interest income -58.32%1.38B48.38%960M151.88%2.15B347.28%1.07B11.88%-2.82B110.93%3.32B-60.93%647M305.71%852M3.46%239M-33.22%-3.2B
Non-operating interest expense -62.13%821M455.87%1.56B84.85%2.07B43.39%542M73.86%-2.1B-41.80%2.17B-91.36%281M-21.97%1.12B30.80%378M-479.45%-8.04B
Total other finance cost ------------8.84%197M----------------48.36%181M----
Other net income (expense) 132.61%1.77B-981.01%-5.43B
Gain on sale of security ------------132.25%1.69B-----------------918.44%-5.24B----
Earnings from equity interest ------------142.86%81M-----------------687.50%-189M----
Income before tax 22.52%34.38B4.44%25.33B29.03%31.92B51.57%104.67B69.28%27.62B55.63%28.06B44.41%24.25B38.05%24.74B16.90%69.06B24.43%16.32B
Income tax 26.82%7.08B9.45%5.28B32.26%6.51B55.06%20.99B107.67%5.66B53.98%5.59B38.80%4.83B32.73%4.92B19.55%13.54B22.65%2.72B
Net income 21.46%27.3B3.20%20.05B28.23%25.41B50.71%83.68B61.59%21.96B56.04%22.48B45.88%19.43B39.44%19.81B16.27%55.53B24.79%13.59B
Net income continuous Operations 21.46%27.3B3.20%20.05B28.23%25.41B50.71%83.68B61.59%21.96B56.04%22.48B45.88%19.43B39.44%19.81B16.27%55.53B24.79%13.59B
Minority interest income
Net income attributable to the parent company 21.46%27.3B3.20%20.05B28.23%25.41B50.71%83.68B61.59%21.96B56.04%22.48B45.88%19.43B39.44%19.81B16.27%55.53B24.79%13.59B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 21.46%27.3B3.20%20.05B28.23%25.41B50.71%83.68B61.59%21.96B56.04%22.48B45.88%19.43B39.44%19.81B16.27%55.53B24.79%13.59B
Basic earnings per share 22.11%6.133.93%4.529.55%5.752.28%18.6762.91%4.9257.37%5.0247.53%4.3341.03%4.417.88%12.2626.36%3.02
Diluted earnings per share 22.40%6.123.94%4.4929.38%5.6852.37%18.6263.12%4.9157.73%547.44%4.3241.16%4.3917.84%12.2226.47%3.01
Dividend per share 15.51%3.4797059.41%6.428126.94%7.0451040.55%3.0126018.37%4.032519.10%5.550
Currency Unit DKKDKKDKKDKKDKKDKKDKKDKKDKKDKK
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Weight Loss Drugs
Weight Loss Drugs
Intraday+0.87%